Greenberg Traurig is a sponsor of DeviceTalks Boston May 10 -11, 2023 at the Boston Covention and Exhibition Center. DeviceTalks is an essential meeting for entrepreneurs, engineers, and other professionals developing the latest tools used to treat patients and cure disease. DeviceTalks Boston will unite Medtech’s most innovative professionals to find the quickest way to clear troublesome bottlenecks in these critical stages: innovation & funding; prototyping and product development; manufacturing & sourcing; regulatory, reimbursement and market development; and engineering tools & technology.
Greenberg Traurig Shareholders David Dykeman and Roman Fayerberg will lead discussion between investors and CEOs about strategic patent portfolio development. The session, "IP Strategy to Attract Funding & Exits," will focus on best practices and pitfalls to avoid to build strategic patent portfolios to close funding, stay competitive, and secure a successful exit. The session will also discuss how to position your medtech company to attract investors, collaborators, and partners.